90
Participants
Start Date
October 7, 2013
Primary Completion Date
January 3, 2018
Study Completion Date
January 3, 2018
Gabapentin
Gabapentin is supplied as an oral suspension. Patients randomized to the gabapentin arm will receive a single dose of gabapentin as soon after enrollment as feasible. The gabapentin dose will be given orally and will be approximately 15 mg/kg with a maximum dose of 900 mg.
Placebo
Placebo will be prepared by the SJCRH pharmacy and will be similar in appearance, quantity and taste to the gabapentin drug. Patients randomized to the placebo arm will receive a single dose of placebo as soon after enrollment as feasible. The placebo dose will be given orally and will be approximately 15 mg/kg with a maximum dose of 900mg.
St. Jude Children's Research Hospital, Memphis
Collaborators (1)
"Scan
UNKNOWN
St. Jude Children's Research Hospital
OTHER